Date published: 2025-12-22

1-800-457-3801

SCBT Portrait Logo
Seach Input

KIAA1704 Inhibitors

KIAA1704 inhibitors are a class of chemical compounds that specifically target and inhibit the activity of the KIAA1704 protein. The KIAA1704 gene, located on human chromosome 17, encodes a protein whose precise function is still under active research, but it is believed to be involved in various cellular processes, including signal transduction and gene expression regulation. By inhibiting this protein, researchers aim to explore its broader role within cellular pathways and its potential impact on key biochemical processes. KIAA1704 inhibitors are designed to bind with high specificity to the protein's active site or key regulatory regions, preventing it from interacting with other cellular components. This inhibition can cause alterations in downstream signaling cascades, making KIAA1704 an attractive subject for fundamental biochemical research.

The study of KIAA1704 inhibitors involves detailed structure-activity relationship (SAR) analysis, where modifications to the chemical structure of these inhibitors help elucidate how the KIAA1704 protein interacts with its inhibitors. Chemical synthesis techniques are utilized to create analogs of known inhibitors, aiming to improve binding affinity, selectivity, and stability. Furthermore, researchers may employ various assays, such as in vitro enzyme assays, to test the effectiveness of different inhibitors in halting KIAA1704 activity. The mechanisms of inhibition are also studied using molecular docking simulations and crystallography to visualize how inhibitors fit within the protein's structure. This deep exploration of the chemical and molecular properties of KIAA1704 inhibitors can significantly advance the understanding of cellular networks and biological systems.

SEE ALSO...

Items 1 to 10 of 11 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Staurosporine

62996-74-1sc-3510
sc-3510A
sc-3510B
100 µg
1 mg
5 mg
$82.00
$150.00
$388.00
113
(4)

A broad-spectrum protein kinase inhibitor, affecting multiple signaling pathways.

MG-132 [Z-Leu- Leu-Leu-CHO]

133407-82-6sc-201270
sc-201270A
sc-201270B
5 mg
25 mg
100 mg
$56.00
$260.00
$980.00
163
(3)

A proteasome inhibitor, impacting protein degradation and the NF-kB pathway.

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$121.00
$392.00
148
(1)

A PI3K inhibitor, affecting cell proliferation and apoptosis.

Rapamycin

53123-88-9sc-3504
sc-3504A
sc-3504B
1 mg
5 mg
25 mg
$62.00
$155.00
$320.00
233
(4)

An mTOR inhibitor, influencing cell growth and protein synthesis.

PD 98059

167869-21-8sc-3532
sc-3532A
1 mg
5 mg
$39.00
$90.00
212
(2)

Another MEK inhibitor, specifically blocking MEK1, thus affecting cell growth and apoptosis.

SB 203580

152121-47-6sc-3533
sc-3533A
1 mg
5 mg
$88.00
$342.00
284
(5)

A p38 MAPK inhibitor, influencing inflammatory responses and cell stress pathways.

SP600125

129-56-6sc-200635
sc-200635A
10 mg
50 mg
$40.00
$150.00
257
(3)

An inhibitor of JNK, involved in stress responses and apoptosis.

Bortezomib

179324-69-7sc-217785
sc-217785A
2.5 mg
25 mg
$132.00
$1064.00
115
(2)

A proteasome inhibitor, used clinically for certain types of cancer.

Thapsigargin

67526-95-8sc-24017
sc-24017A
1 mg
5 mg
$94.00
$349.00
114
(2)

An inhibitor of SERCA, affecting calcium homeostasis.

Z-VAD-FMK

187389-52-2sc-3067
500 µg
$74.00
256
(6)

A broad-spectrum caspase inhibitor, impacting apoptosis pathways.